Marcia Allen - Feb 16, 2023 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role: Director
Signature: /s/ Marcia Allen
Stock symbol: INMB
Transactions as of: Feb 16, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/21/2023, 03:02 PM
Previous filing: Mar 23, 2022
Next filing: May 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INMB	Option (right to buy)	Award	$0	+35K		$0.00	35K	Feb 16, 2023	Common Stock	35K	$9.74	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	19,024 options granted pursuant to the 2021 Stock Incentive Plan, 7,313 options granted pursuant to the 2019 Stock Incentive Plan and 8,663 options granted pursuant to the 2017 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.

Content

19,024 options granted pursuant to the 2021 Stock Incentive Plan, 7,313 options granted pursuant to the 2019 Stock Incentive Plan and 8,663 options granted pursuant to the 2017 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.